Logo image of XBIO

XENETIC BIOSCIENCES INC (XBIO) Stock Analyst Earnings Estimates

NASDAQ:XBIO - Nasdaq - US9840156023 - Common Stock - Currency: USD

2.79  -0.03 (-1%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
XBIO revenue by date.XBIO revenue by date.
1.71M
47.41%
2.54M
48.54%
2.5M
-1.56%
2.754M
10.15%
3.06M
11.11%
2.55M
-16.67%
EBITDA
YoY % growth
XBIO ebitda by date.XBIO ebitda by date.
N/A
-20.63%
-4.516M
34.89%
N/A
-40.04%
-4.386M
30.65%
-8.058M
-83.72%
-12.342M
-53.16%
EBIT
YoY % growth
XBIO ebit by date.XBIO ebit by date.
-6.72M
-16.87%
-4.516M
32.80%
-3.5M
22.49%
-4.386M
-25.31%
-8.058M
-83.72%
-12.342M
-53.16%
Operating Margin
XBIO operating margin by date.XBIO operating margin by date.
-392.98%-177.78%-139.98%-159.26%-263.33%-484.00%
EPS
YoY % growth
XBIO eps by date.XBIO eps by date.
-4.70
-737.79%
-2.75
41.49%
-2.57
6.55%
-2.61
-1.60%
-4.55
-74.22%
-0.44
90.36%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.50
-78.50%
-0.53
22.00%
Revenue
Q2Q % growth
642.6K
4.62%
703.8K
8.61%
EBITDA
Q2Q % growth
-816K
46.67%
-918K
57.14%
EBIT
Q2Q % growth
-816K
-63.36%
-918K
16.48%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.45
45.78%
-0.650.2031.07%
Q1 2025
Q2Q % growth
-0.59
24.36%
-0.730.1419.66%
Q4 2024
Q2Q % growth
-0.68
11.69%
-0.20-0.48-233.33%
Q3 2024
Q2Q % growth
-0.28
59.42%
-0.14-0.14-96.08%
Q2 2024
Q2Q % growth
-0.83
-20.29%
-0.850.021.96%
Q1 2024
Q2Q % growth
-0.78
-30.00%
-0.810.033.20%
Q4 2023
Q2Q % growth
-0.77
23.00%
-0.890.1213.23%
Q3 2023
Q2Q % growth
-0.69
-15.00%
-1.140.4539.60%
Q2 2023
Q2Q % growth
-0.69
63.68%
-1.150.4640.14%
Q1 2023
Q2Q % growth
-0.60
50.00%
-1.120.5246.52%
Q4 2022
Q2Q % growth
-1.00
-553.59%
-0.92-0.08-8.93%
Q3 2022
Q2Q % growth
-0.60
-361.54%
-1.841.2467.32%
Q2 2022
Q2Q % growth
-1.90
-1,361.54%
-1.22-0.68-55.23%
Q1 2022
Q2Q % growth
-1.20
-700.00%
-1.12-0.08-6.95%
Q4 2021
Q2Q % growth

4.38%
-0.15%
Q3 2021
Q2Q % growth
-0.13
-148.15%
-0.12-0.01-6.21%
Q2 2021
Q2Q % growth
-0.13
13.33%
-0.160.0320.34%
Q1 2021
Q2Q % growth
-0.15
21.05%
-0.13-0.02-13.12%
Q4 2020
Q2Q % growth
-0.16
20.40%
-0.200.0421.57%
Q3 2020
Q2Q % growth
0.27 -0.160.43270.78%
Q2 2020
Q2Q % growth
-0.15 -0.220.0733.16%
Q1 2020
Q2Q % growth
-0.19 -0.380.1949.66%
Q4 2019
Q2Q % growth
-0.20 -0.390.1948.14%
XBIO Yearly EPS VS EstimatesXBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2019 2020 2021 2022 2023 2024 2025 2026 2027 -50 -100 -150
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
589.9K
-18.79%
652.8K-62.9K-9.64%
Q1 2025
Q2Q % growth
593.26K
16.14%
683.4K-90.14K-13.19%
Q4 2024
Q2Q % growth
648K
-3.57%
234.6K413.4K176.21%
Q3 2024
Q2Q % growth
614.24K
0.50%
765K-150.76K-19.71%
Q2 2024
Q2Q % growth
726.4K
11.58%
550.8K175.6K31.88%
Q1 2024
Q2Q % growth
510.82K
-15.68%
663K-152.18K-22.95%
Q4 2023
Q2Q % growth
672K
37.14%
693.6K-21.6K-3.11%
Q3 2023
Q2Q % growth
611.17K
49.07%
489.6K121.57K24.83%
Q2 2023
Q2Q % growth
651.01K
55.00%
448.8K202.21K45.06%
Q1 2023
Q2Q % growth
605.84K
55.34%
418.2K187.64K44.87%
Q4 2022
Q2Q % growth
490K
48.48%
204K286K140.20%
Q3 2022
Q2Q % growth
410K
17.14%
357K53K14.85%
Q2 2022
Q2Q % growth
420K
44.83%
346.8K73.2K21.11%
Q1 2022
Q2Q % growth
390K
105.26%
346.8K43.2K12.46%
Q4 2021
Q2Q % growth
330K
120.00%
102K228K223.53%
Q3 2021
Q2Q % growth
350K
191.67%
204K146K71.57%
Q2 2021
Q2Q % growth
290K
163.64%
193.8K96.2K49.64%
Q1 2021
Q2Q % growth
190K
216.67%
61.2K128.8K210.46%
Q4 2020
Q2Q % growth
150K
650.00%
121.89K28.11K23.06%
Q3 2020
Q2Q % growth
120K 98.94K21.06K21.29%
Q2 2020
Q2Q % growth
110K 61.2K48.8K79.74%
XBIO Yearly Revenue VS EstimatesXBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 18.99% 0% 20.99%
Revenue0% -7.25% 0% -3.57%